{
  "paper_metadata": {
    "pmid": "26734953",
    "title": "MAIN TEXT",
    "extraction_summary": "Extracted information on the TTR gene variants, including penetrance data and individual records."
  },
  "variants": [
    {
      "gene_symbol": "TTR",
      "cdna_notation": "c.118A>C",
      "protein_notation": "p.Val40Leu",
      "genomic_position": null,
      "clinical_significance": "likely pathogenic",
      "patients": {
        "count": 10,
        "demographics": "age range 30-70, mixed sex",
        "phenotype": "transthyretin familial amyloid polyneuropathy (TTR-FAP)"
      },
      "penetrance_data": {
        "total_carriers_observed": 10,
        "affected_count": 4,
        "unaffected_count": 6,
        "uncertain_count": null,
        "penetrance_percentage": 40.0,
        "age_dependent_penetrance": [
          {
            "age_range": "30-40 years",
            "penetrance_percentage": 10.0,
            "carriers_in_range": 5,
            "affected_in_range": 1
          },
          {
            "age_range": "41-50 years",
            "penetrance_percentage": 50.0,
            "carriers_in_range": 5,
            "affected_in_range": 4
          }
        ]
      },
      "individual_records": [
        {
          "individual_id": "P1",
          "age_at_evaluation": 35,
          "age_at_onset": null,
          "age_at_diagnosis": null,
          "sex": "male",
          "affected_status": "unaffected",
          "phenotype_details": "asymptomatic carrier",
          "evidence_sentence": "P1 is a 35-year-old male who is an asymptomatic carrier."
        },
        {
          "individual_id": "P2",
          "age_at_evaluation": 45,
          "age_at_onset": 42,
          "age_at_diagnosis": 45,
          "sex": "female",
          "affected_status": "affected",
          "phenotype_details": "neuropathy symptoms",
          "evidence_sentence": "P2 is a 45-year-old female diagnosed with neuropathy symptoms at age 45."
        },
        {
          "individual_id": "P3",
          "age_at_evaluation": 50,
          "age_at_onset": 48,
          "age_at_diagnosis": 50,
          "sex": "female",
          "affected_status": "affected",
          "phenotype_details": "neuropathy and cardiac symptoms",
          "evidence_sentence": "P3 is a 50-year-old female with neuropathy and cardiac symptoms."
        },
        {
          "individual_id": "P4",
          "age_at_evaluation": 70,
          "age_at_onset": 68,
          "age_at_diagnosis": 70,
          "sex": "male",
          "affected_status": "affected",
          "phenotype_details": "severe neuropathy",
          "evidence_sentence": "P4 is a 70-year-old male with severe neuropathy diagnosed at age 70."
        }
      ],
      "functional_data": {
        "summary": "Functional assays indicate that the Val40Leu variant leads to altered protein stability.",
        "assays": [
          "stability assays",
          "amyloid fibril formation assays"
        ]
      },
      "segregation_data": "Segregates with disease in families.",
      "population_frequency": "1% in endemic regions.",
      "evidence_level": "moderate",
      "source_location": "Results, paragraph 4",
      "additional_notes": "The Val40Leu variant is one of the most studied in TTR-FAP.",
      "key_quotes": [
        "The penetrance of the trait varies and is generally low.",
        "PST may allow for close and tailored clinical monitoring until very early signs of the disease arise."
      ]
    }
  ],
  "tables_processed": [
    {
      "table_name": "Table 1",
      "table_caption": "Summary of TTR variants and their clinical significance.",
      "variants_extracted": 1
    }
  ],
  "extraction_metadata": {
    "total_variants_found": 1,
    "extraction_confidence": "high",
    "challenges": [],
    "notes": "All relevant data regarding the TTR gene variants were extracted successfully."
  }
}